Kreitzer Anatol has filed 5 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 6020 shares of MapLight Therapeutics, Inc. ($MPLT) on February 05, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kreitzer Anatol | Chief Discovery Officer | A | Voting Common Stock | 6020 | $0.00 | 259,928.0000 | 45,373,033 | 2.37% | 0.01% |
| Feb. 5, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kreitzer Anatol | Chief Discovery Officer | A | Employee Stock Option (right to buy) | 24455 | $0.00 | 24,455.0000 | 45,373,033 | 9999.99% | 0.05% |
| Jan. 27, 2026 | MapLight Therapeutics, Inc. | $MPLT | Kreitzer Anatol | Chief Discovery Officer | F | Voting Common Stock | 42099 | $17.98 | 253,908.0000 | 45,373,033 | 14.22% | 0.09% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kreitzer Anatol | Chief Discovery Officer | A | Voting Common Stock | 35953 | $0.00 | 35,953.0000 | 0 | 9999.99% | 0.00% |
| Oct. 27, 2025 | MapLight Therapeutics, Inc. | $MPLT | Kreitzer Anatol | Chief Discovery Officer | A | Employee Stock Option (right to buy) | 146052 | $0.00 | 146,052.0000 | 0 | 9999.99% | 0.00% |